285 related articles for article (PubMed ID: 7359351)
1. Cardiovascular profile of mixidine fumarate, a compound which attenuates myocardial chronotropic responses.
Pruss TP; Hageman WE; Jacoby HI
J Pharmacol Exp Ther; 1980 Mar; 212(3):514-8. PubMed ID: 7359351
[TBL] [Abstract][Full Text] [Related]
2. Role of force--frequency relation during AV-block, sinus node block and beta-adrenoceptor block in conscious animals.
De Pauw M; Vilaine JP; Heyndrickx GR
Basic Res Cardiol; 2004 Sep; 99(5):360-71. PubMed ID: 15338245
[TBL] [Abstract][Full Text] [Related]
3. Effects of epinephrine, isoproterenol and IPS-339 on sympathetic transmission to the dog heart: evidence against the facilitatory role of presynaptic beta adrenoceptors.
Yorikane R; Kanda A; Kimura T; Satoh S
J Pharmacol Exp Ther; 1986 Jul; 238(1):334-40. PubMed ID: 3014122
[TBL] [Abstract][Full Text] [Related]
4. Selective inhibition by zatebradine and discrete parasympathetic stimulation of the positive chronotropic response to sympathetic stimulation in anesthetized dogs.
Furukawa Y; Nakano H; Oguchi T; Kasama M; Hoyano Y; Chiba S
J Pharmacol Exp Ther; 1995 Feb; 272(2):744-9. PubMed ID: 7853189
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological studies of mabuterol, a new selective beta 2-stimulant. II: Effects on the cardiovascular system and smooth muscle organs.
Osada E; Murai T; Ishizaka Y; Sanai K
Arzneimittelforschung; 1984; 34(11A):1641-51. PubMed ID: 6152157
[TBL] [Abstract][Full Text] [Related]
6. [General pharmacological actions of traxanox sodium. II. Effects on the cardiovascular system].
Nakamura T; Miura Y; Aihara K; Satoh H; Goto K; Tsumagari T
Nihon Yakurigaku Zasshi; 1983 Jul; 82(1):79-92. PubMed ID: 6137441
[TBL] [Abstract][Full Text] [Related]
7. Predominance of postsynaptic mechanism in vagal suppression of sympathetic tachycardia in the dog.
Kimura T; Uchida W; Satoh S
J Pharmacol Exp Ther; 1985 Dec; 235(3):793-7. PubMed ID: 3001277
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular actions of mixidine fumarate.
Takeda K; Akera T; Brody TM
Eur J Pharmacol; 1980 Nov; 68(2):129-37. PubMed ID: 7202482
[No Abstract] [Full Text] [Related]
9. Comparison of cardiovascular responses to the bradycardic drugs, alinidine, AQ-A 39, and mixidine, in the anesthetized dog.
Siegl PK; Wenger HC; Sweet CS
J Cardiovasc Pharmacol; 1984; 6(4):565-74. PubMed ID: 6206308
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular actions of buflomedil and possible mechanisms involved.
Kushiku K; Ohba M; Mikagi T; Nuki S; Araki Y; Furukawa T
Arzneimittelforschung; 1989 Jun; 39(6):670-7. PubMed ID: 2775333
[TBL] [Abstract][Full Text] [Related]
11. Beta-blocking and hemodynamic effects of ASL-8052.
Gorczynski RJ; Murthy VS; Hwang TF
J Cardiovasc Pharmacol; 1984; 6(6):1548-59. PubMed ID: 6084788
[TBL] [Abstract][Full Text] [Related]
12. The cardiovascular and autonomic properties of N-phenylpiperazine (NPP) in several animal models.
Cohen MR; Hinsch E; Palkoski Z; Vergona R; Urbano S; Sztokalo J
J Pharmacol Exp Ther; 1982 Oct; 223(1):110-9. PubMed ID: 6126578
[TBL] [Abstract][Full Text] [Related]
13. General pharmacology of the novel angiotensin converting enzyme inhibitor alacepril. 1st communication: Effects on cardiovascular, visceral and renal functions and on blood.
Matsuno Y; Taira N; Fujitani B; Ito T; Kadokawa T
Arzneimittelforschung; 1986; 36(1):55-62. PubMed ID: 3513777
[TBL] [Abstract][Full Text] [Related]
14. An evaluation of the inability of cocaine to potentiate the responses to cardiac sympathetic nerve stimulation in the dog.
Koerker RL; Moran NC
J Pharmacol Exp Ther; 1971 Sep; 178(3):482-96. PubMed ID: 5571899
[No Abstract] [Full Text] [Related]
15. [Cardiodynamics of the conscious dog undergoing treadmill exercise, blood pressure reduction or isoproterenol and its modification by beta-blockade].
Lehmann HD
Dtsch Tierarztl Wochenschr; 1985 Apr; 92(4):135-9. PubMed ID: 3899576
[No Abstract] [Full Text] [Related]
16. Systemic, pulmonary and coronary haemodynamic actions of the novel dopamine receptor agonist in awake pigs at rest and during treadmill exercise Z1046.
Duncker DJ; Haitsma DB; van der Geest IE; Stubenitsky R; van Meegen JR; Man in't Veld AJ; Verdouw PD
Br J Pharmacol; 1997 Mar; 120(6):1101-13. PubMed ID: 9134223
[TBL] [Abstract][Full Text] [Related]
17. Effects of brotizolam on cardiovascular functions and autonomic nervous system.
Kushiku K; Morishita H; Furukawa T; Kitagawa H; Ueno K; Kitagawa H; Kohei H
Arzneimittelforschung; 1986 Mar; 36(3A):552-9. PubMed ID: 3718577
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo assessment of the cardiovascular effects of the cardiotonic drug MDL 19205.
Roebel LE; Dage RC; Cheng HC; Woodward JK
J Cardiovasc Pharmacol; 1984; 6(1):43-9. PubMed ID: 6199610
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of the chronotropic effects of prostacyclin in the dog: comparison with the actions of prostaglandin E2.
Chiba S; Malik KU
J Pharmacol Exp Ther; 1980 May; 213(2):261-6. PubMed ID: 6988574
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular pharmacology of bepridil (1[3 isobutoxy 2 (benzylphenyl) amino] propyl pyrrolidine hydrochloride) a new potential anti-anginal compound.
Cosnier D; Duchenne-Marullaz P; Rispat G; Streichenberger G
Arch Int Pharmacodyn Ther; 1977 Jan; 225(1):133-51. PubMed ID: 849059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
